Fish & Richardson Principal Joseph Warden Named Law360 2018 Life Sciences "Rising Star"

Fish & Richardson principal Joseph Warden has been selected as a 2018 Life Sciences "Rising Star" by Law360. The award honors attorneys under the age of 40 with notable accomplishments in their practice area. Warden, who is based in the firm's Delaware office, was one of only five attorneys selected for the Life Sciences Rising Star distinction.

Earlier this year, in a decision that has been hailed as one of the biggest litigation comebacks of all time, Warden argued the damages segment of the Judgment as a Matter of Law (JMOL) that reversed a $2.5 billion jury verdict- the largest patent damages award in history - against client Gilead Sciences Inc. The case, Idenix Pharmaceuticals LLC et al. v. Gilead Sciences Inc., is part of an ongoing global dispute between Gilead and Merck & Co./Idenix over Gilead's two blockbuster drugs, Sovaldi® and Harvoni®, which cure hepatitis C and are considered by many to be the greatest medical innovation of our lifetimes.

Warden was also heavily involved in the Gilead Sciences Inc. v. Merck & Co. Inc., et al. trial over the same hepatitis c drugs. He second chaired the damages portion of the March 2016 trial. Merck was asking for over $2 billion, but the jury awarded Merck only $200 million. That award was subsequently reversed in June 2016 after the Fish team proved litigation and business misconduct by Merck and that the case was "exceptional." Warden led the subsequent briefing that netted Gilead $14 million in attorneys' fees in July 2017.

Warden received his J.D., Order of the Coif, from the University of Virginia School of Law in 2009 and his B.A. from Brigham Young University in 2005.